Geisinger Cancer Services-Pottsville — Pottsville, Pennsylvania

Geisinger Cancer Services-Pottsville is a clinical research site located in Pottsville, Pennsylvania, United States 17901.

Crixeo Clinical Trials Trust Score: 33/100 (FAILING). This profile has not yet been claimed by the site owner.

Geisinger Cancer Services-Pottsville has participated in 150 clinical trials with 108 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pottsville

Browse all research sites in Pennsylvania · View every site in Pottsville

Sponsor Feasibility Report

Trust Score: 33/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Geisinger Cancer Services-Pottsville?

Geisinger Cancer Services-Pottsville has a Crixeo Trust Score of 33/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Geisinger Cancer Services-Pottsville conducted?

Geisinger Cancer Services-Pottsville has 150 clinical trials on record, with 108 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Geisinger Cancer Services-Pottsville accredited by Crixeo Clinical Trials?

Geisinger Cancer Services-Pottsville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Geisinger Cancer Services-Pottsville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.